Projects per year
Fingerprint
Dive into the research topics where Pui-Kai Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
DEVELOPMENT OF MELATONIN RECEPTOR LIGANDS
Li, P.-K. (PI)
National Institute of Neurological Disorders and Stroke
04/27/00 → 12/31/04
Project: Research
-
Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma
Zhong, Y., Geng, F., Mazik, L., Yin, X., Becker, A. P., Mohammed, S., Su, H., Xing, E., Kou, Y., Chiang, C. Y., Fan, Y., Guo, Y., Wang, Q., Li, P. K., Mo, X., Lefai, E., He, L., Cheng, X., Zhang, X. & Chakravarti, A. & 1 others, , Sep 17 2024, In: Cell Reports Medicine. 5, 9, 101706.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Design, Synthesis, and Biological Evaluation of Selective TBL1X Degraders
Yang, R., Pray, B., Alinari, L., Li, P.-K. & Cheng, X., Oct 10 2024, In: ACS Medicinal Chemistry Letters. 15, 10, p. 1699-1707 9 p.Research output: Contribution to journal › Article › peer-review
-
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy
Ning, S., Armstrong, C. M., Xing, E., Leslie, A. R., Gao, R. Y., Sharifi, M., Schaaf, Z. A., Lou, W., Han, X., Xu, D. H., Yang, R., Cheng, J., Mohammed, S., Mitsiades, N., Liu, C., Lombard, A. P., Wu, C. Y., Cheng, X., Li, P. K. & Gao, A. C., Nov 2024, In: Cancer Research. 84, 21, p. 3617-3628 12 p.Research output: Contribution to journal › Article › peer-review
-
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications
To, K. K. W., Xing, E., Larue, R. C. & Li, P. K., Apr 2023, In: Molecules. 28, 7, 3043.Research output: Contribution to journal › Review article › peer-review
Open Access33 Scopus citations -
Computational modeling studies reveal the origin of the binding preference of 3-(3,4-di hydroisoquinolin-2(1H)-ylsulfonyl)benzoic acids for AKR1C3 over its isoforms
Kong, X., Xing, E., Wu, S., Zhuang, T., Li, P. K., Li, C. & Cheng, X., Dec 2022, In: Protein Science. 31, 12, e4499.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations